Citations

Clear

949 citation(s) found for "Li, Bryan".

Pulmonary Open, Robotic, and Thoracoscopic Lobectomy (PORTaL) Study
Hartwig, Matthew G. , Abbas, Abbas E. , Dylewski, Mark, Fabian, Thomas , Jett, Kimble, Meyers, Bryan , Reddy, Rishindra M. , Rice, David C. , Ross, Patrick, Sarkaria, Inderpal S., Schumacher, Lana , Spier, Lawrence N., Tisol, William B., Wigle, Dennis A. , Zervos, Michael , Herrera, Luis Javier Pentón , Kent, Michael Sean , Cerfolio, Robert J. , Herrera, Luis J., Lazzaro, Richard S. , Reed, Michael F.

Mayo Clinic

Annals of Surgery | February 10, 2023 | Volume: 277 | Issue: 6 | Pages: 1002-1009

10.1097/sla.0000000000005820 | PMID 36762564 Get It

Objective: The aim of this study was to analyze overall survival (OS) of robotic-assisted lobectomy (RL), video-assisted thoracoscopic lobectomy (VATS), and open lobectomy (OL) performed by experienced thoracic surgeons across multiple institutions. Summary Background Data: Surgeons have increasingly adopted RL for resection of early-stage lung cancer. Comparative survival data following these approaches is largely from single-institution case series or administrative data sets. Methods: Retrospective data was collected from 21 institutions from 2013 to 2019. Consecutive cases performed for clinical stage IA–IIIA lung cancer were included. Induction therapy patients were excluded. The propensity-score method of inverse-probability of treatment weighting was used to balance baseline characteristics. OS was estimated using the Kaplan-Meier method. Multivariable Cox proportional hazard models were used to evaluate association among OS and relevant risk factors. Results: A total of 2789 RL, 2661 VATS, and 1196 OL cases were included. The unadjusted 5-year OS rate was highest for OL (84%) followed by RL (81%) and VATS (74%); P=0.008. Similar trends were also observed after inverse-probability of treatment weighting adjustment (RL 81%; VATS 73%, OL 85%, P=0.001). Multivariable Cox regression analyses revealed that OL and RL were associated with significantly higher OS compared with VATS (OL vs. VATS: hazard ratio=0.64, P<0.001 and RL vs. VATS: hazard ratio=0.79; P=0.007). Conclusions: Our finding from this large multicenter study suggests that patients undergoing RL and OL have statistically similar OS, while the VATS group was associated with shorter OS. Further studies with longer follow-up are necessary to help evaluate these observations.
Human Airway Basal Cells Undergo Reversible Squamous Differentiation and Reshape Innate Immunity
Black, Katharine E., Phung, Thien‐Khoi N. , Thundivalappil, Sujatha, Xu, Jie , Lapey, Allen , Lerou, Paul H. , Que, Jianwen, Park, Jin‐Ah , Hurley, Bryan P. , Mou, Hongmei , Que, Jianwen , Mou, Hongmei , Park, Jin-Ah , Que, Jianwen , Zhang, Yihan , Lin, Tian , Wang, Wei , Zhang, Cheng , Hariri, Lida P. , Li, Hu , Ai, Xingbin

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | February 8, 2023 | Volume: 68 | Issue: 6 | Pages: 664-678

10.1165/rcmb.2022-0299oc | PMID 36753317 Get It

Abstract Histological and lineage immunofluorescence examination revealed that healthy conducting airways of humans and animals harbor sporadic poorly differentiated epithelial patches mostly in the dorsal noncartilage regions that remarkably manifest squamous differentiation. In vitro analysis demonstrated that this squamous phenotype is not due to intrinsic functional change in underlying airway basal cells. Rather, it is a reversible physiological response to persistent Wnt signaling stimulation during de novo differentiation. Squamous epithelial cells have elevated gene signatures of glucose uptake and cellular glycolysis. Inhibition of glycolysis or a decrease in glucose availability suppresses Wnt-induced squamous epithelial differentiation. Compared with pseudostratified airway epithelial cells, a cascade of mucosal protective functions is impaired in squamous epithelial cells, featuring increased epithelial permeability, spontaneous epithelial unjamming, and enhanced inflammatory responses. Our study raises the possibility that the squamous differentiation naturally occurring in healthy airways identified herein may represent “vulnerable spots” within the airway mucosa that are sensitive to damage and inflammation when confronted by infection or injury. Squamous metaplasia and hyperplasia are hallmarks of many airway diseases, thereby expanding these areas of vulnerability with potential pathological consequences. Thus, investigation of physiological and reversible squamous differentiation from healthy airway basal cells may provide critical knowledge to understand pathogenic squamous remodeling, which is often nonreversible, progressive, and hyperinflammatory.
Lack of hierarchical survival prognosis in AJCC staging for colon cancer: Implications for future summary stage classification.
Hu, Chung‐Yuan , Palis, Bryan E., Cotler, Joseph H. , Goldberg, Richard M. , Nelson, Heidi , Steele, Scott, Chang, George J. , Bhutiani, Neal , Shi, Qian , Washington, Mary Kay

Mayo Clinic

Journal of Clinical Oncology | January 24, 2023 | Volume: 41 | Issue: 4_suppl | Pages: 256-256

10.1200/jco.2023.41.4_suppl.256 Get It

256 Background: Current staging for colon cancer utilizing the American Joint Committee on Cancer TNM framework stratifies disease into groups according to how advanced the disease is and provides important standardized, individual prognostic information. Ideally, staging systems should exhibit hierarchical logic, with increasing stage reflecting worse prognosis. We sought to evaluate hierarchy within the 8th edition AJCC staging system for colon cancer. Methods: All patients with primary colon (including rectosigmoid) cancer diagnosed 2010-2017 were identified from the National Cancer Database (NCDB). Patients were only included if they carried a histologic diagnosis of invasive primary (non-recurrent) cancer, underwent radical surgery, and had complete pathologic staging data (T, N, M category data). Patients with missing follow-up data were excluded. Kaplan-Meier curves were used to assess overall survival by AJCC 8th edition pathologic summary stage group to determine whether staging was hierarchical for colon cancer. Multivariable modeling and log likelihood ratio test was then used to identify relative contributions of T and N variables to overall survival. Results: Among 270,584 colon cancer patients, pathologic staging was noted to be hierarchical by T category alone and by N category alone. However, summary staging was non-hierarchical in both instances. Multivariable modeling confirmed the AJCC non-hierarchy issue (colon HRs: 1, 1.54, 2.62, 2.60, 1.02, 2.15, and 4.38 for stage 1 as reference, 2a, 2b, 2c, 3a, 3b, 3c respectively). Multivariable modeling demonstrated that high T category (T4a, T4b) conferred the greatest risk of mortality based on hazard ratio (T4a HR 2.76, T4b HR 3.04), while high T category as well as high N category (N2a, N2b) contributed substantially to the survival model based on z-score. Further modeling assessing the predictive power of T and N category with respect to overall survival demonstrated that T category more strongly predicted overall survival than N category in colon cancer (likelihood chi-square test statistic pT:7009 vs pN:3586). Conclusions: Hierarchy in survival based on AJCC summary stage was not observed for patients with stage II-III colon cancer resulting in a paradoxical better observed survival with some stage III cancer subgroups compared to stage II cancer subgroups. High T category appears to more significantly impact survival than N category for patients with N0-N1 disease, while high N category appears more important for patients with T1-3 disease. Future revisions of the AJCC staging system should account for the differential impact of T and N category identified herein to more accurately confer prognostic information.
Non-invasive detection of cardiac allograft rejection among heart transplant recipients using an electrocardiogram based deep learning model
Adedinsewo, Demilade , Hardway, Heather D , Morales-Lara, Andrea Carolina , Wieczorek, Mikolaj A. , Douglass, Erika J. , Dangott, Bryan, Nakhleh, Raouf E. , Narula, Tathagat , Patel, Parag C. , Lyle, Melissa , Heckman, Alexander , Leoni-Moreno, Juan Carlos, Steidley, D. Eric , Hardaway, Brian , Abbas, Mohsin, Friedman, Paul A. , Carter, Rickey E. , Yamani, Mohamad H. , Douglass, Erika J , Dangott, Bryan J, Narula, Tathagat , Heckman, Alexander J, Leoni-Moreno, Juan C, Attia, Zachi I , Lopez-Jimenez, Francisco , Yamani, Mohamad, Carter, Rickey E , Adedinsewo, Demilade A , Hardway, Heather , Johnson, Patrick W. , Goswami, Rohan , Arsanjani, Reza , Behfar, Atta , Attia, Zachi I. , López-Jiménez, Francisco , Noseworthy, Peter A.

Mayo Clinic

European Heart Journal - Digital Health | January 13, 2023 | Volume: 4 | Issue: 2 | Pages: 71-80

10.1093/ehjdh/ztad001 | PMID 36974261 Get It

Abstract Aims Current non-invasive screening methods for cardiac allograft rejection have shown limited discrimination and are yet to be broadly integrated into heart transplant care. Given electrocardiogram (ECG) changes have been reported with severe cardiac allograft rejection, this study aimed to develop a deep-learning model, a form of artificial intelligence, to detect allograft rejection using the 12-lead ECG (AI-ECG). Methods and results Heart transplant recipients were identified across three Mayo Clinic sites between 1998 and 2021. Twelve-lead digital ECG data and endomyocardial biopsy results were extracted from medical records. Allograft rejection was defined as moderate or severe acute cellular rejection (ACR) based on International Society for Heart and Lung Transplantation guidelines. The extracted data (7590 unique ECG-biopsy pairs, belonging to 1427 patients) was partitioned into training (80%), validation (10%), and test sets (10%) such that each patient was included in only one partition. Model performance metrics were based on the test set (n = 140 patients; 758 ECG-biopsy pairs). The AI-ECG detected ACR with an area under the receiver operating curve (AUC) of 0.84 [95% confidence interval (CI): 0.78–0.90] and 95% (19/20; 95% CI: 75–100%) sensitivity. A prospective proof-of-concept screening study (n = 56; 97 ECG-biopsy pairs) showed the AI-ECG detected ACR with AUC = 0.78 (95% CI: 0.61–0.96) and 100% (2/2; 95% CI: 16–100%) sensitivity. Conclusion An AI-ECG model is effective for detection of moderate-to-severe ACR in heart transplant recipients. Our findings could improve transplant care by providing a rapid, non-invasive, and potentially remote screening option for cardiac allograft function.
Anti-inflammatory effects of PDMP in Pneumocystis pneumonia (133.1)
Vuk-Pavlović, Zvezdana, Forsythe, Marshaleen Henriques, Krajicek, Bryan J. , Behrens, Marshall D., Knutson, Keith L. , Knutson, Keith L. , Limper, Andrew H.

Mayo Clinic

The Journal of Immunology | December 31, 2022 | Volume: 182 | Issue: Supplement_1 | Pages: 133.1-133.1

10.4049/jimmunol.182.supp.133.1 Get It

Abstract Glycosphingolipid (GSL) Lactosyl Ceramide (LacCer) is thought to be involved in Pneumocystis interaction with the host. Our previous results show that treatment with glycosphingolipid synthesis inhibitor PDMP reduces the fungus lung burden as well as symptoms of inflammation in mice with Pneumocystis pneumonia (PCP). Experiments were set up to resolve whether anti-inflammatory effects were due to the specific mechanisms involved in innate immune responses to Pneumocystis, or to some general anti-inflammatory property of PDMP. Animals were infected with live organisms, or challenged with either beta-glucan (the pro-inflammatory component of Pneumocystis cell wall) or LPS (inducer of lung inflammation unrelated to Pneumocystis). At the experimental endpoint the following inflammatory parameters were assessed: leukocyte recruitment to the lungs, production of pro-inflammatory cytokines and chemokines, histopathology and lung damage. Results show that glucan-induced acute inflammation partially mimics the inflammation caused by the whole organism, and PDMP suppresses some of the inflammatory parameters affected in PCP. In contrast, although LPS induces comparable intensity of inflammation as live Pneumocystis or glucan, PDMP does not suppress any inflammatory parameters measured in this group. These results suggest that the mechanism of PDMP action is related to the features specific to Pneumocystis and host recognition of the microorganism. Further studies will attempt to determine the role of LacCer in these processes. Supported by NIH-RO1-HL62150 and Mayo Clinic
Deep Brain Stimulator Device Infection: The Mayo Clinic Rochester Experience
Tabaja, Hussam , Tai, Don Bambino Geno , Chesdachai, Supavit , Hassan, Anhar , Klassen, Bryan T. , Miller, Kai J. , Lee, Kendall H. , Yuen, Jason , Campioli, Cristina Corsini , Mahmood, Maryam , Chesdachai, Supavit , Tai, Don Bambino Geno , Tabaja, Hussam , DeSimone, Daniel C. , Mahmood, Maryam

Mayo Clinic

Open Forum Infectious Diseases | December 26, 2022 | Volume: 10 | Issue: 1 | Pages: No page available

10.1093/ofid/ofac631 | PMID 36632420 Get It

Abstract Background Deep brain stimulator (DBS)–related infection is a recognized complication that may significantly alter the course of DBS therapy. We describe the Mayo Clinic Rochester experience with DBS-related infections. Methods This was a retrospective study of all adults (≥18 years old) who underwent DBS-related procedures between 2000 and 2020 at the Mayo Clinic Rochester. Results There were 1087 patients who underwent 1896 procedures. Infection occurred in 57/1112 (5%) primary DBS implantations and 16/784 (2%) revision surgeries. The median time to infection (interquartile range) was 2.1 (0.9–6.9) months. The odds of infection were higher with longer operative length (P = .002), higher body mass index (BMI; P = .006), male sex (P = .041), and diabetes mellitus (P = .002). The association between infection and higher BMI (P = .002), male sex (P = .016), and diabetes mellitus (P = .003) remained significant in a subgroup analysis of primary implantations but not revision surgeries. Infection was superficial in 17 (23%) and deep in 56 (77%) cases. Commonly identified pathogens were Staphylococcus aureus (65%), coagulase-negative staphylococci (43%), and Cutibacterium acnes (45%). Three device management approaches were identified: 39 (53%) had complete device explantation, 20 (27%) had surgical intervention with device retention, and 14 (19%) had medical management alone. Treatment failure occurred in 16 (23%) patients. Time-to-event analysis showed fewer treatment failures with complete device explantation (P = .015). Only 1 individual had complications with brain abscess at failure. Conclusions Primary DBS implantations had higher rates of infection compared with revision surgeries. Complete device explantation was favored for deep infections. However, device salvage was commonly attempted and is a reasonable approach in select cases given the low rate of complications.
Cognition Before and After COVID-19 Disease in Older Adults: An Exploratory Study
Caselli, Richard J. , Chen, Yinghua , Bauer, Robert, Woodruff, Bryan K. , Chen, Kewei , Locke, Dona E.C.

Mayo Clinic

Journal of Alzheimer's Disease | December 9, 2022 | Volume: 91 | Issue: 3 | Pages: 1049-1058

10.3233/jad-220435 | PMID 36502320 Get It

Background: Older age is a major risk factor for severe COVID-19 disease which has been associated with a variety of neurologic complications, both acutely and chronically. Objective: We sought to determine whether milder COVID-19 disease in older vulnerable individuals is also associated with cognitive and behavioral sequelae. Methods: Neuropsychological, behavioral, and clinical outcomes before and after contracting COVID-19 disease, were compared in members of two ongoing longitudinal studies, the Arizona APOE Cohort and the national Alzheimer’s Disease Research Center (ADRC). Results: 152 APOE and 852 ADRC cohort members, mean age overall roughly 70 years, responded to a survey that indicated 21 APOE and 57 ADRC members had contracted COVID-19 before their ensuing (post-COVID) study visit. The mean interval between test sessions that preceded and followed COVID was 2.2 years and 1.2 years respectively for the APOE and ADRC cohorts. The magnitude of change between the pre and post COVID test sessions did not differ on any neuropsychological measure in either cohort. There was, however, a greater increase in informant (but not self) reported cognitive change in the APOE cohort (p = 0.018), but this became nonsignificant after correcting for multiple comparisons. Conclusion: Overall members of both cohorts recovered well despite their greater age-related vulnerability to more severe disease.
A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL): Results of the ECOG-ACRIN EA9131 Trial
Jillella, Anand P., Altman, Jessica K. , Luger, Selina M. , Tallman, Martin S. , Foran, James M. , Law, Lisa Y. , Bryan, Locke J. , Zahr, Abdallah Abou, Begna, Kebede, Perl, Alexander E. , Vadakara, Joseph , Sánchez, Federico , Carlos, Ruth C. , Litzow, Mark R. , Lee, Sandra J. , Bergan, Raymond C. , Fisch, Michael , Wagner, Lynne I. , Kota, Vamsi

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1011-1013

10.1182/blood-2022-163436 Get It

A practical guide to the development and deployment of deep learning models for the Orthopedic surgeon: part I
Nwachukwu, Benedict U. , Martin, R. Kyle , Kelly, Bryan T. , Pearle, Andrew D. , Pareek, Ayoosh , Oeding, Jacob F. , Williams, Riley J. , Karlsson, Jón , Camp, Christopher L. , Ranawat, Anil S.

Mayo Clinic

Knee Surgery, Sports Traumatology, Arthroscopy | November 25, 2022 | Volume: 31 | Issue: 2 | Pages: 382-389

10.1007/s00167-022-07239-1 | PMID 36427077 Get It

AbstractDeep learning has a profound impact on daily life. As Orthopedics makes use of this rapid escalation in technology, Orthopedic surgeons will need to take leadership roles on deep learning projects. Moreover, surgeons must possess an understanding of what is necessary to design and implement deep learning‐based project pipelines. This review provides a practical guide for the Orthopedic surgeon to understand the steps needed to design, develop, and deploy a deep learning pipeline for clinical applications. A detailed description of the processes involved in defining the problem, building the team, acquiring and curating the data, labeling the data, establishing the ground truth, pre‐processing and augmenting the data, and selecting the required hardware is provided. In addition, an overview of unique considerations involved in the training and evaluation of deep learning models is provided. This review strives to provide surgeons with the groundwork needed to identify gaps in the clinical landscape that deep learning models may be able to fill and equips them with the knowledge needed to lead an interdisciplinary team through the process of creating novel deep‐learning‐based solutions to fill those gaps.
The Effects of Deep Brain Stimulation in Patients with Multiple System Atrophy
Jackson, Lauren , Klassen, Bryan T. , Hassan, Anhar , Low, Phillip A. , Badihian, Negin , Jackson, Lauren M, Singer, Wolfgang , Coon, Elizabeth A.

Mayo Clinic

Journal of Parkinson's Disease | November 22, 2022 | Volume: 12 | Issue: 8 | Pages: 2595-2600

10.3233/jpd-223504 | PMID 36442207 Get It

The course of patients with multiple system atrophy (MSA) who undergo deep brain stimulation (DBS) is unclear. In a retrospective review of 1,496 patients with MSA evaluated at our institutions from 1998–2021, 12 patients underwent DBS; 9 had a diagnosis of Parkinson’s disease at the time of surgery. Nine patients reported initial improvement in at least one symptom and 7 experienced overall worsening following DBS. All patients had at least one red flag sign or symptom suggesting atypical parkinsonism prior to surgery. Considering overall poor outcomes of DBS in MSA, we recommend careful consideration of red flags in patient selection.